🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cohance Lifesciences Limited (BOM:543064)
India flag India · Delayed Price · Currency is INR
462.00
+2.85 (0.62%)
At close: Nov 20, 2026

Cohance Lifesciences Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Cohance Lifesciences stock has a consensus rating of "Hold" and an average price target of ₹510.50. The average 1-year stock price forecast is 10.50% higher than the current stock price, while the lowest is ₹280.00 (-39.39%) and the highest is ₹1,150 (+148.92%).

Price Target: ₹510.50 (+10.50%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price₹280.00₹510.50₹460.00₹1,150
Change-39.39%+10.50%-0.43%+148.92%

Analyst Ratings

The average analyst rating for Cohance Lifesciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy444455
Buy000000
Hold111111
Sell222221
Strong Sell222223
Total99991010

Financial Forecast

Revenue This Year
23.89B
from 22.69B
Increased by 5.33%
Revenue Next Year
28.74B
from 23.89B
Increased by 20.26%
EPS This Year
5.00
from 5.24
Decreased by -4.57%
EPS Next Year
8.87
from 5.00
Increased by 77.51%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027E
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
13.20B13.40B10.51B26.09B22.69B23.89B
Revenue Growth
30.75%1.52%-21.56%148.11%-13.03%5.33%
Gross Profit
7.46B7.52B6.80B16.65B14.64B17.24B
Gross Margin
56.51%56.11%64.65%63.85%64.55%72.13%
Operating Income
5.42B5.26B3.54B6.61B2.41B1.88B
Net Income
4.54B4.11B3.00B4.87B1.79B1.86B
EPS
----5.245.00
EPS Growth
-----49.88%-4.57%
Forward PE
-----92.43
Dividend / Share
2.003.00---0.10
Free Cash Flow
----1.48B1.33B
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High35.5B
Avg23.9B
Low21.2B

Revenue Growth

Revenue Growth202720282029
High
56.5%
Avg
5.3%
Low
-6.7%

EPS Forecast

EPS202720282029
High5.83
Avg5.00
Low3.40

EPS Growth

EPS Growth202720282029
High
11.3%
Avg
-4.6%
Low
-35.1%